Atrophic Gastritis and Vitamin B12: What It Means

Atrophic Gastritis and Vitamin B12: What It Means

← Patient Education

Atrophic gastritis is a long-term change in the stomach lining in which the glands that make acid and other digestive substances are slowly lost after years of inflammation. It usually causes no symptoms of its own, and many people first hear the term on an upper endoscopy biopsy report or after a blood test shows low vitamin B12 or iron. This page explains what atrophic gastritis is, its two main causes, how it connects to vitamin B12 deficiency and pernicious anemia, how it is diagnosed, and what follow-up usually looks like, based on the American Gastroenterological Association (AGA) Clinical Practice Update on atrophic gastritis and the American College of Gastroenterology (ACG) guideline on gastric premalignant conditions.

This article is general education, not medical advice. If you have a biopsy report or blood test result you have questions about, review it with the physician who ordered it.

What atrophic gastritis is

The AGA defines atrophic gastritis as the loss of gastric glands, with or without a change called metaplasia, in the setting of chronic inflammation. In plain terms, the lining of the stomach has been inflamed for a long time, and some of its normal glands have shrunk or disappeared. They may be replaced by scar-like connective tissue, or by a different type of cell that does not belong in the stomach.

The most common replacement is intestinal metaplasia, where stomach cells are replaced by cells that look like the lining of the intestine. The AGA points out that intestinal metaplasia on a biopsy almost always means atrophic gastritis is present too, because metaplasia develops in lining that has already become atrophic. Pathology reports do not always say this directly, so a report that mentions only intestinal metaplasia is still describing the same process.

Atrophic gastritis is different from the more familiar, short-term irritation of the stomach that causes burning or nausea. Our page on gastritis covers that broader topic. Atrophic gastritis is a slow, structural change that develops over years.

How common atrophic gastritis is

The AGA estimates that atrophic gastritis affects up to 15% of people in the United States. It is more common in groups with higher rates of H. pylori infection or stomach cancer, including some racial and ethnic minority groups and people who were born in, or whose parents came from, countries where stomach cancer is more common. Because it is usually silent and is not always described clearly on pathology reports, the AGA describes it as frequently underdiagnosed.

The two main causes of atrophic gastritis

The AGA and the ACG both describe two main causes. They behave differently, affect different parts of the stomach, and lead to somewhat different follow-up.

H. pylori-associated atrophic gastritis

Long-term infection with H. pylori, a common stomach bacterium, is by far the most common cause. The AGA cites a meta-analysis in which atrophic gastritis developed about five times more often in people with H. pylori than without it, and less than 1% per year in people who were never infected. In this type, the changes usually begin in the lower part of the stomach, called the antrum, and the nearby bend called the incisura. Over many years the patches can join and spread upward into the body of the stomach. The AGA also lists older age, tobacco use, a high-salt diet, and possibly long-term bile reflux as risk factors.

Autoimmune gastritis

In autoimmune gastritis, the immune system makes antibodies against the parietal cells, the cells in the upper body of the stomach that make acid and a protein called intrinsic factor. The ACG describes progressive inflammation that eventually replaces this lining. Unlike the H. pylori type, autoimmune gastritis mainly affects the body and top of the stomach and spares the antrum.

The AGA estimates that autoimmune gastritis affects roughly 0.5% to 2% of people, and notes that this may be an overestimate. It becomes more common with age, is more common in women, and is linked to other autoimmune conditions, especially autoimmune thyroid disease and type 1 diabetes. The AGA cites an estimate that up to one in three people with autoimmune thyroid disease have autoimmune gastritis. The two causes can overlap, and some people have features of both.

Atrophic gastritis and vitamin B12

The stomach plays two roles in absorbing vitamin B12. Acid helps release B12 from food, and intrinsic factor, made by the parietal cells, binds B12 so the small intestine can absorb it. When atrophic gastritis involves the body of the stomach, both can fall. The AGA notes that people with corpus-predominant atrophic gastritis, from either cause, are at increased risk of both iron and vitamin B12 deficiency.

Pernicious anemia

Pernicious anemia is a late stage of autoimmune gastritis. The AGA describes it as vitamin B12 deficiency with a type of anemia in which red blood cells are larger than normal. By the time pernicious anemia appears, the AGA says, the atrophy in the stomach has usually been present for at least several years. It is less common than autoimmune gastritis itself: the AGA estimates a prevalence of about 0.15% to 1%.

MedlinePlus, from the National Library of Medicine, lists symptoms of pernicious anemia that can include tiredness, lightheadedness, shortness of breath with exertion, pale skin, a sore red tongue, loss of appetite, and diarrhea or constipation. A low B12 level over a long time can affect the nerves, with numbness and tingling in the hands and feet, loss of balance, memory problems, or depression. MedlinePlus notes that nerve damage can become permanent if treatment is delayed, which is one reason unexplained B12 deficiency deserves a clear answer.

How B12 deficiency is treated

According to MedlinePlus, treatment aims to raise the B12 level. It often involves a B12 shot once a month, with more frequent shots at first for people whose levels are very low. Some people can be treated adequately with large doses of B12 by mouth, and a nasal spray form exists. Which approach fits you, and how often levels are checked, is a decision for your physician. Replacing B12 treats the deficiency, but it does not reverse the change in the stomach lining, so the stomach itself still needs its own plan.

Iron deficiency often comes first

Stomach acid also helps the body absorb iron from food. The AGA reports that some series found iron deficiency in up to half of people with corpus-predominant atrophic gastritis, and that it often shows up well before B12 deficiency does. The AGA advises checking for both deficiencies in anyone with atrophic gastritis, and, in the other direction, considering atrophic gastritis when iron or B12 deficiency has no other explanation. Our page on iron deficiency anemia explains how gastroenterologists look for digestive causes of low iron.

Symptoms of atrophic gastritis

The AGA describes atrophic gastritis as typically causing no symptoms, or only vague ones that may appear later. When symptoms do appear, they more often come from what it leads to than from the stomach lining itself:

  • Signs of low B12 or iron. Tiredness, shortness of breath, pale skin, or numbness and tingling, as described above.
  • Upper digestive symptoms. Some people notice indigestion, fullness, or nausea, though these are common and have many other causes. Our page on functional dyspepsia covers ongoing indigestion more broadly.
  • Findings from other autoimmune conditions. For example, thyroid symptoms in a person who also has autoimmune gastritis.

Because the condition is often silent, many people learn they have it only after an endoscopy done for another reason, or after a blood test. Our page on digestive conditions that are often silent covers other examples.

How atrophic gastritis is diagnosed

The AGA states that, regardless of the cause, atrophic gastritis should be confirmed by looking at biopsy tissue under a microscope. A blood test alone, or the appearance of the stomach during a scope, is not enough.

Upper endoscopy and biopsies

An upper endoscopy lets the gastroenterologist look at the stomach lining directly. The AGA describes atrophic lining as often looking pale and thin, with blood vessels more visible and fewer of the normal folds. The changes can be subtle, so the AGA calls for a careful, high-quality exam: a well-cleaned and inflated stomach, enough time spent looking, and photographs of each region.

Biopsies are taken in a set pattern. The AGA recommends the updated Sydney protocol, which takes five samples from defined areas of the antrum, the incisura, and the body of the stomach. At a minimum, samples from the body and from the antrum and incisura should go into separately labeled jars, so the pathologist can tell which part of the stomach is affected. This matters because the pattern helps tell the H. pylori type from the autoimmune type, and because more extensive atrophy carries more risk. Any spot that looks unusual is sampled separately.

Blood tests for autoimmune gastritis

When biopsies fit autoimmune gastritis, the AGA advises considering blood tests for antibodies against parietal cells and against intrinsic factor. The AGA explains that parietal cell antibodies are the more sensitive test but can be positive for other reasons, including H. pylori infection and other autoimmune diseases. Intrinsic factor antibodies are less often positive, but a positive result is more specific. The AGA also advises checking iron and B12 levels and, for autoimmune gastritis, screening for autoimmune thyroid disease.

Testing for H. pylori

Both the AGA and the ACG advise that everyone with atrophic gastritis be checked for H. pylori, including people with the autoimmune type. The ACG specifies a test that is not a blood antibody test, such as a stool, breath, or biopsy test.

Treatment of atrophic gastritis

There is no medicine that rebuilds lost stomach glands. Care for atrophic gastritis focuses on treating H. pylori when it is present, replacing what the body is missing, and watching for complications.

Treating H. pylori

If H. pylori is found, both societies recommend treating it and then retesting afterward, again with a test that is not a blood antibody test, to confirm the infection is gone. The AGA notes that the lining can recover over time in some people after the infection is cleared, but that many have passed a point where the damage does not reverse. Even then, the AGA reports that treating H. pylori still appears to lower stomach cancer risk.

Replacing B12 and iron

When blood tests show low B12 or low iron, replacement is part of care. Because absorption from food can stay low, these deficiencies can return, so your physician may check levels periodically. Our page on long-term acid-reducing medicine covers a separate question many people ask about B12 and PPIs.

Atrophic gastritis and stomach cancer risk

Atrophic gastritis is called a preneoplastic condition, meaning it is an early step in a slow chain of changes that, in a small number of people, can lead to stomach cancer. The AGA describes that chain as atrophic gastritis, then intestinal metaplasia, then dysplasia, and then cancer. It is important to keep the size of that risk in perspective. The AGA estimates the yearly risk of progression from atrophic gastritis to stomach cancer at about 0.1% to 0.3%, similar to nondysplastic Barrett's esophagus or low-risk colon polyps, and notes that only a small minority of people with atrophic gastritis develop cancer. The risk is higher when the atrophy is more extensive or severe, when intestinal metaplasia is present, and with a family history of stomach cancer.

For pernicious anemia, the AGA cites a pooled analysis showing a higher relative risk of stomach cancer, with most individual studies suggesting about two to four times the risk. Both the AGA and the ACG note that this risk may be highest in the first year after pernicious anemia is diagnosed.

Our page on stomach cancer covers risk factors, warning signs, and the ACG's surveillance advice for intestinal metaplasia in more detail.

Gastric neuroendocrine tumors

When parietal cells are lost, the stomach makes less acid, and the body responds by making more of a hormone called gastrin. Over time, high gastrin can cause certain cells in the stomach lining to grow, and in a small number of people this leads to small growths called type 1 gastric neuroendocrine tumors, sometimes called carcinoids. The AGA estimates their yearly incidence in chronic atrophic gastritis at about 0.4% to 0.7%. These tumors are usually small, slow-growing, and found by chance, and they can look like polyps. The AGA advises removing small ones, under 1 centimeter, during endoscopy, and then considering a repeat endoscopy every 1 to 2 years depending on how many there are. Our page on stomach polyps explains what else can appear as a growth on an upper endoscopy.

Follow-up endoscopy for atrophic gastritis

Neither society sets one fixed schedule for everyone. Here is what each says:

  • Advanced atrophic gastritis. The AGA advises considering a surveillance endoscopy every 3 years for people with advanced atrophic gastritis, judged by how much of the stomach is involved and how severe the changes are. It notes that shorter or longer intervals may fit depending on individual risk.
  • Factors that can shorten the interval. The AGA lists the quality of the first exam, a family history of stomach cancer, immigration from a region where stomach cancer is more common, H. pylori that persists, and smoking.
  • Autoimmune gastritis. The AGA calls the right interval unclear and advises an individualized plan. The ACG says there is not enough evidence for a formal recommendation, and that individualized surveillance may be considered because of the higher risk of neuroendocrine tumors and possibly stomach cancer.
  • New pernicious anemia. The AGA advises an upper endoscopy with mapped biopsies for people newly diagnosed with pernicious anemia who have not had a recent one. The ACG says endoscopy should be considered, with particular attention to women over age 50.

A follow-up plan is a shared decision. It weighs these factors along with your overall health and your own priorities.

Questions to ask about atrophic gastritis

  • Does my biopsy show the H. pylori type, the autoimmune type, or both?
  • How much of my stomach is affected, and does my report include a stage?
  • Was intestinal metaplasia found, and where?
  • Have I been tested for H. pylori with a breath, stool, or biopsy test, and was a cleared infection confirmed?
  • Should my B12, iron, or thyroid levels be checked, and how often?
  • Do I need a follow-up endoscopy, and when?

Atrophic gastritis care in Northern Virginia

Gastroenterology Center of Northern Virginia cares for adults across Arlington, Annandale, and the surrounding communities. Our physicians perform upper endoscopy, test for and treat H. pylori, evaluate unexplained iron and B12 deficiency, and review prior pathology reports with patients to explain what a finding means and what, if anything, comes next. If this is your first visit, our guide to your first gastroenterologist visit explains what to bring, including prior endoscopy and pathology reports and recent blood test results.

We see patients at our Arlington office at 1715 N George Mason Drive, adjacent to VHC Health, and our Annandale office at 3299 Woodburn Road in the Woodburn Medical complex. To schedule a visit, call Arlington at (703) 522-7476 or Annandale at (703) 560-6106, or learn more at gcofnova.com.

Frequently asked questions about atrophic gastritis

Is atrophic gastritis serious?

It is worth taking seriously, but for most people it is not dangerous. The AGA estimates the yearly risk of it progressing to stomach cancer at about 0.1% to 0.3%, and only a small minority of people develop cancer. The bigger everyday concerns are low vitamin B12 and iron, which are treatable, and making a follow-up plan with your gastroenterologist.

What is the difference between atrophic gastritis and autoimmune gastritis?

Atrophic gastritis is the broad term for loss of stomach glands after long-term inflammation. Autoimmune gastritis is one cause of it, in which the immune system attacks acid-making cells in the upper body of the stomach. The most common cause overall is long-term H. pylori infection, which usually starts in the lower stomach.

Does atrophic gastritis cause vitamin B12 deficiency?

It can. When atrophic gastritis involves the body of the stomach, the stomach makes less acid and less intrinsic factor, both of which help absorb B12. The AGA advises checking B12 and iron in people with atrophic gastritis, and considering atrophic gastritis in anyone with B12 or iron deficiency that has no other explanation.

Can atrophic gastritis be reversed?

Sometimes, partly. The AGA notes that the lining may recover over time in some people after H. pylori is treated, but many have damage that does not reverse. Treating H. pylori still appears to lower stomach cancer risk even when the atrophy remains. There is no treatment that regrows lost glands in autoimmune gastritis.

How is atrophic gastritis diagnosed?

With an upper endoscopy and biopsies. The AGA says the diagnosis should be confirmed by examining tissue, using a set biopsy pattern that samples both the lower and upper parts of the stomach in separate jars. Blood tests for parietal cell and intrinsic factor antibodies can support a diagnosis of the autoimmune type.

How often do I need an endoscopy with atrophic gastritis?

It depends on how extensive the changes are and on your other risk factors. The AGA advises considering an endoscopy every 3 years for advanced atrophic gastritis. For autoimmune gastritis, both the AGA and ACG say the right interval is not established and the plan should be individualized. Your gastroenterologist will set a schedule based on your biopsy results and history.

This article is for general education and is not medical advice. Figures and recommendations described here come from the American Gastroenterological Association Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis (2021), the American College of Gastroenterology clinical guideline on gastric premalignant conditions (2025), and MedlinePlus from the National Library of Medicine, and your own care depends on your symptoms, your history, and your physician's judgment. Talk with a qualified gastroenterologist about your results, diagnosis, and treatment options.

About us



We would like to welcome you to the Gastroenterology Center of Northern Virginia, Ltd. We appreciate the opportunity to participate in your care. It is our sincere desire to provide you with the highest quality and most comprehensive services in the diagnosis, treatment and management of various digestive conditions.

Arlington Address


1715 N George Mason Dr, Suite 403, Arlington, VA 22205
(adjacent to VHC Health, Zone C,
Parking C )
Phone: (703) 522-7476
Fax: (703) 528-4209
Office hours:
Monday – Thursday 8:30 am – 5:00 pm
Friday 8:30 am – 4:30 pm

Annandale Address


3299 Woodburn Road, Suite 220 Annandale, VA 22003
(second building in the Woodburn Medical complex)
Phone: (703) 560-6106
Fax: (703) 204-1968
Office hours:
Monday - Thursday 8:30 am – 5:00 pm
Friday 8:30 am – 4:30 pm
Copyright - 2019 Gastroenterology Center of Northern Virginia. All rights reserved.